Concepedia

Mingchao Xie

MX

13

Publications

1K

Citations

11

H-Index

2005

Active since

Affiliations

AstraZeneca (United States)(Current)

Memorial Sloan Kettering Cancer Center

Hospital Universitario 12 De Octubre

AstraZeneca (United Kingdom)

Foundation Medicine (United States)

Mingchao Xie is an author at AstraZeneca (United States) specializing in medicine, pathology, and molecular genetics.

ORCID

Top concepts

Publications per year

2005–2023

13

Publications

13

Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project

Diana M. Merino, Lisa M. McShane, David Fabrizio et al. · Journal for ImmunoTherapy of Cancer · 2020 · 491 citations · Full text

Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project

Diana Merino Vega, Laura M. Yee, Lisa M. McShane et al. · Annals of Oncology · 2021 · 174 citations · Full text

The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis

Kevin B. Jones, Jared J. Barrott, Mingchao Xie et al. · Oncogene · 2016 · 56 citations · Full text

, , +8

<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1

Theresa A. Proia, Maneesh Singh, Richard Woessner et al. · Clinical Cancer Research · 2020 · 50 citations · Full text

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

Luis Paz‐Ares, Marina Chiara Garassino, Yuanbin Chen et al. · Clinical Cancer Research · 2023 · 50 citations · Full text

Rows per page

1–5 of 13